The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FOLFOXIRI/bevacizumab (bev) versus doublets/bev as initial therapy of unresectable liver-only, right-sided and/or RAS or BRAF mutated (mut) metastatic colorectal cancer (mCRC): An individual patient data-based pooled analysis of randomized trials.
 
Carlotta Antoniotti
Honoraria - Merck
Travel, Accommodations, Expenses - Merck
 
Federica Marmorino
No Relationships to Disclose
 
Fabian Maximilian Meinert
No Relationships to Disclose
 
Francesca Bergamo
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Pierre Fabre; SERVIER
Speakers' Bureau - Bayer; BMS; Eisai; Lilly; MSD Oncology
Travel, Accommodations, Expenses - Advanced Accelerator Applications/Novartis
 
Giuseppe Tonini
Consulting or Advisory Role - Italfarmaco; Molteni Farmaceutici; Novartis; Pierre Fabre; Roche
Research Funding - Novartis (Inst); PharmaMar (Inst)
 
Daniele Rossini
Speakers' Bureau - Amgen; MSD Oncology
 
Beatrice Borelli
No Relationships to Disclose
 
Antonio De Rosa
No Relationships to Disclose
 
Giacomo Allegrini
No Relationships to Disclose
 
Alexander Stein
Consulting or Advisory Role - Amgen (Inst); AstraZeneca; Bristol-Myers Squibb (Inst); Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); Merck KGaA; MSD (Inst); Novartis (Inst); Pierre Fabre (Inst); Pierre Fabre (Inst); Roche; SERVIER (Inst); Taiho Oncology (Inst)
Speakers' Bureau - Bristol-Myers Squibb (Inst); Daiichi Sankyo Europe GmbH (Inst); Merck KGaA; Seagen (Inst); Servier
Research Funding - Bristol-Myers Squibb (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Pierre Fabre (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH
 
Roberto Moretto
No Relationships to Disclose
 
Monica Ronzoni
No Relationships to Disclose
 
Alberto Zaniboni
Consulting or Advisory Role - Amgen; Bayer; Merck; Merck Serono; Servier
Speakers' Bureau - Astellas Pharma (Inst); servier
 
Marco Maria Germani
No Relationships to Disclose
 
Sara Sperotto
No Relationships to Disclose
 
Elena Ongaro
No Relationships to Disclose
 
Filippo Ghelardi
No Relationships to Disclose
 
Gianluca Masi
Consulting or Advisory Role - AstraZeneca; Eisai; MSD Oncology; Roche; Roche
Research Funding - Terumo (Inst); Terumo (Inst)
Patents, Royalties, Other Intellectual Property - Terumo (Inst)
 
Hans Schmoll
No Relationships to Disclose
 
Chiara Cremolini
Honoraria - Amgen; Bayer; Merck; Merck; MSD; Pierre Fabre; Roche; SERVIER
Consulting or Advisory Role - Amgen; Bayer; MSD; Nordic Bioscience; Pierre Fabre; Roche
Speakers' Bureau - Merck; Pierre Fabre; SERVIER
Research Funding - Bayer; Merck; Roche; SERVIER